In this study, we found that elevated CRP ≥ 1.025 mg/dL significantly increased the risk of developing orbital complications in IFS patients, and a CRP level ≥ 6.91 mg/dL was significantly associated with poorer prognosis in IFSwOC patients. Here, CRP is linked to congenital fibrosarcoma.